Literature DB >> 10757800

STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.

P K Datta1, H L Moses.   

Abstract

Smad proteins play a key role in the intracellular signaling of the transforming growth factor beta (TGF-beta) superfamily of extracellular polypeptides that initiate signaling from the cell surface through serine/threonine kinase receptors. A subclass of Smad proteins, including Smad6 and Smad7, has been shown to function as intracellular antagonists of TGF-beta family signaling. We have previously reported the identification of a WD40 repeat protein, STRAP, that associates with both type I and type II TGF-beta receptors and that is involved in TGF-beta signaling. Here we demonstrate that STRAP synergizes specifically with Smad7, but not with Smad6, in the inhibition of TGF-beta-induced transcriptional responses. STRAP does not show cooperation with a C-terminal deletion mutant of Smad7 that does not bind with the receptor and consequently has no inhibitory activity. STRAP associates stably with Smad7, but not with the Smad7 mutant. STRAP recruits Smad7 to the activated type I receptor and forms a complex. Moreover, STRAP stabilizes the association between Smad7 and the activated receptor, thus assisting Smad7 in preventing Smad2 and Smad3 access to the receptor. STRAP interacts with Smad2 and Smad3 but does not cooperate functionally with these Smads to transactivate TGF-beta-dependent transcription. The C terminus of STRAP is required for its phosphorylation in vivo, which is dependent on the TGF-beta receptor kinases. Thus, we describe a mechanism to explain how STRAP and Smad7 function synergistically to block TGF-beta-induced transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757800      PMCID: PMC85610          DOI: 10.1128/MCB.20.9.3157-3167.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  New clues to how proteins link up to run the cell.

Authors:  M Barinaga
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells.

Authors:  A Ishisaki; K Yamato; S Hashimoto; A Nakao; K Tamaki; K Nonaka; P ten Dijke; H Sugino; T Nishihara
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules.

Authors:  P J Lu; X Z Zhou; M Shen; K P Lu
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

4.  Homomeric interactions between type II transforming growth factor-beta receptors.

Authors:  R H Chen; R Derynck
Journal:  J Biol Chem       Date:  1994-09-09       Impact factor: 5.157

5.  A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor.

Authors:  R H Chen; P J Miettinen; E M Maruoka; L Choy; R Derynck
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

6.  Repression of transforming growth factor beta 1 promoter by the adenovirus oncogene E1A. Identification of a unique GC-rich sequence as a target for E1A repression.

Authors:  P K Datta; S Bagchi
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

7.  Signal transduction by transforming growth factor-β: A cooperative paradigm with extensive negative regulation.

Authors:  Michael E Engel; Pran K Datta; Harold L Moses
Journal:  J Cell Biochem       Date:  1998       Impact factor: 4.429

8.  Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.

Authors:  M R Keeton; S A Curriden; A J van Zonneveld; D J Loskutoff
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

9.  GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.

Authors:  R Wieser; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

10.  The types II and III transforming growth factor-beta receptors form homo-oligomers.

Authors:  Y I Henis; A Moustakas; H Y Lin; H F Lodish
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

View more
  59 in total

1.  Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.

Authors:  M Furuhashi; K Yagi; H Yamamoto; Y Furukawa; S Shimada; Y Nakamura; A Kikuchi; K Miyazono; M Kato
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Conditional switches for extracellular matrix patterning in Drosophila melanogaster.

Authors:  Arvinder Khokhar; Nan Chen; Ji-Ping Yuan; Yishi Li; Gary N Landis; Gregory Beaulieu; Harminder Kaur; John Tower
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

3.  Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.

Authors:  Shi-Ling Song; Zuo-Jiong Gong; Quan-Rong Zhang; Tuan-Xin Huang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

4.  Smad6 inhibits the transcriptional activity of Tbx6 by mediating its degradation.

Authors:  Yue-Lei Chen; Bin Liu; Zhen-Ning Zhou; Rui-Ying Hu; Cong Fei; Zhi-Hui Xie; Xiaoyan Ding
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

5.  A crucial role for the phosphorylation of STRAP at Ser(188) by MPK38 in STRAP-dependent cell death through ASK1, TGF-β, p53, and PI3K/PDK1 signaling pathways.

Authors:  Hyun-A Seong; Ravi Manoharan; Hyunjung Ha
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1.

Authors:  Lin Jin; Pran K Datta
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Targeting the transforming growth factor-beta signaling pathway in human cancer.

Authors:  Nagathihalli S Nagaraj; Pran K Datta
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

Review 8.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

9.  Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.

Authors:  Daizo Koinuma; Masahiko Shinozaki; Akiyoshi Komuro; Kouichiro Goto; Masao Saitoh; Aki Hanyu; Masahito Ebina; Toshihiro Nukiwa; Keiji Miyazawa; Takeshi Imamura; Kohei Miyazono
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

10.  Local network topology in human protein interaction data predicts functional association.

Authors:  Hua Li; Shoudan Liang
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.